Lv1
40 积分 2024-12-05 加入
Artificial Intelligence–Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study
13天前
已完结
Chinese nonmedicinal herbal diet and risk of nasopharyngeal carcinoma: A population‐based case‐control study
14天前
已完结
Surgical and pathological results following neoadjuvant nivolumab and platinum-based chemotherapy for locally advanced resectable NSCLC. A multicentre real-world series from England
15天前
已完结
Sintilimab: First Global Approval
16天前
已完结
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer
16天前
已完结
Lung cancer: current therapies and new targeted treatments
18天前
已完结
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
18天前
已完结
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
19天前
已完结
NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 7.2025
19天前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer: final analysis of the randomized RATIONALE-315 trial
20天前
已完结
皖公网安备34019202002308
